Compare AQN & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AQN | AMRX |
|---|---|---|
| Founded | 1988 | 2002 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 3.8B |
| IPO Year | 1998 | N/A |
| Metric | AQN | AMRX |
|---|---|---|
| Price | $6.11 | $12.37 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 4 |
| Target Price | $6.54 | ★ $13.25 |
| AVG Volume (30 Days) | ★ 3.9M | 1.8M |
| Earning Date | 11-07-2025 | 10-30-2025 |
| Dividend Yield | ★ 4.27% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | $2,387,738,000.00 | ★ $2,934,959,000.00 |
| Revenue This Year | $4.72 | $9.99 |
| Revenue Next Year | $3.99 | $6.67 |
| P/E Ratio | ★ N/A | $766.27 |
| Revenue Growth | 2.90 | ★ 9.50 |
| 52 Week Low | $4.19 | $6.69 |
| 52 Week High | $6.48 | $12.68 |
| Indicator | AQN | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 58.53 | 59.32 |
| Support Level | $5.74 | $12.12 |
| Resistance Level | $6.21 | $12.53 |
| Average True Range (ATR) | 0.10 | 0.32 |
| MACD | 0.01 | -0.04 |
| Stochastic Oscillator | 75.53 | 68.55 |
Algonquin Power & Utilities Corp is a Canada-based diversified international generation, transmission, and distribution company. The company's operations are organized across two business units consisting of the Regulated Services Group, which owns and operates a portfolio of regulated electric, water distribution and wastewater collection, and natural gas utility systems and transmission operations in the United States, Canada, Bermuda, and Chile; and the Hydro Group, which consists of hydroelectric-generating facilities located in Canada. It generates the majority of its revenue from the Regulated Services Group segment.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.